A randomized-controlled trial investigating the impact of high-intensity interval training on the kynurenine pathway in persons with Multiple Sclerosis
Not Applicable
Recruiting
- Conditions
- G35.1
- Registration Number
- DRKS00033055
- Lead Sponsor
- Technische Universität Dortmund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Declaration of no-objection concerning study participation by a physician
- EDSS = 4
- Approved RRMS
Exclusion Criteria
- Acute episode or exacerbation of multiple sclerosis symptoms during intervention
- Concomitant disease state (medical/ neurological) affecting study endpoints (e.g., tumor diseases)
- Cardio-vascular or orthopedic diseases excluding from the exercise program
- Pregnancy or breast feeding
- Adjustments in MS-specific medication within 12 weeks prior to participation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method kynurenine/tryptophan ratio (measured in blood serum at all 4 measurement time points)
- Secondary Outcome Measures
Name Time Method